Home Blog Page 64

Blog

Pharma Marketing Blog

Most popular

FDA Study is Designed to Justify a New BadAd Program for...

Pharma Guy - January 9, 2017

U.S. e-Detailing Spending Up 74% in 2012. Yet Pharma Still NOT...

Pharma Guy - April 18, 2013

Deconstructing Pitts’ Guiding Principles for Pharma Social Media

Pharma Guy - November 28, 2011

Pfizer Reveals (Almost) All Payments to Physicians

Pharma Guy - April 6, 2010

Gifts That Keep on Giving

Pharma Guy - January 27, 2006

Is CME in the US Doomed? Or Just For-Profit MECC’s?

Pharma Guy - June 12, 2009

Dear FDA: Where Are the Public Comments Regarding Regulation of Internet,...

Pharma Guy - December 2, 2009

Brain Drugs: This is Your Brain on Adderall

Pharma Guy - December 8, 2008

Merck’s Hand in the Cookie Jar

Pharma Guy - December 9, 2005

Actos Launches DTC Attack on Avandia

Pharma Guy - July 15, 2010

1...636465...240 Page 64 of 240

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Researcher analyzing genetic data for an ultra-rare disease alongside physicians, DNA imagery, and patient silhouettes representing rare disease awareness and patient identification.

How Do You Market a Disease That Doesn’t Officially Exist?

August 6, 2026

Healthcare professional reviewing a plain-language clinical trial summary with a patient, illustrating how transparent communication strengthens trust, patient engagement, and pharmaceutical marketing.

The Plain-Language Revolution: How Compliance Is Becoming a Marketing Advantage

August 5, 2026

Healthcare professional reviewing a personalized medication dosing plan, illustrating flexible dosing strategies that support patient persistence and individualized treatment.

Could Flexible Dosing Become Pharma’s Next Competitive Advantage?

August 4, 2026